{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:55Z","timestamp":1792783375514,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the State Key Projects Specialized on Infectious Disease","award":["2018ZX10725506"],"award-info":[{"award-number":["2018ZX10725506"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970525"],"award-info":[{"award-number":["81970525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Key Research Project of Special Clinical Application","award":["Z151100004015221"],"award-info":[{"award-number":["Z151100004015221"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10388-7","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T05:03:15Z","timestamp":1666069395000},"page":"1379-1389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus \u03b2-blocker"],"prefix":"10.1007","volume":"16","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiguo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1972-7712","authenticated-orcid":false,"given":"Fuquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-1095","authenticated-orcid":false,"given":"Yongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"10388_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"10388_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u20131314","journal-title":"Lancet"},{"key":"10388_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer","year":"2012","unstructured":"European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u2013943","journal-title":"J Hepatol"},{"key":"10388_CR4","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20131022","journal-title":"Hepatology"},{"key":"10388_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/JHC.S224938","volume":"7","author":"AL Raybould","year":"2020","unstructured":"Raybould AL, Sanoff H. Combination antiangiogenic and immunotherapy for advanced hepatocellular carcinoma: evidence to date. J Hepatocell Carcinoma. 2020;7:133\u2013142","journal-title":"J Hepatocell Carcinoma"},{"key":"10388_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/hep.26120","volume":"57","author":"A Duffy","year":"2013","unstructured":"Duffy A, Wilkerson J, Greten TF. Hemorrhagic events in hepatocellular carcinoma patients treated with anti-angiogenic therapies. Hepatology. 2013;57:1068\u20131077","journal-title":"Hepatology"},{"key":"10388_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/2050640615615041","volume":"4","author":"L Massimo","year":"2016","unstructured":"Massimo L, Massimo P, Sara V, et al. Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib. United Eur Gastroenterol J. 2016;4:363\u2013370","journal-title":"United Eur Gastroenterol J"},{"key":"10388_CR8","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.2147\/DDDT.S151241","volume":"12","author":"X Li","year":"2018","unstructured":"Li X, Wan J, Wu Z, et al. Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Drug Des Dev Ther. 2018;12:3043\u20133049","journal-title":"Drug Des Dev Ther"},{"key":"10388_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65:310\u2013335","journal-title":"Hepatology"},{"key":"10388_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1056\/NEJMoa1912484","volume":"382","author":"YW James","year":"2020","unstructured":"James YW, Lau YY, Tang RSY, et al. Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med. 2020;382:1299\u20131308","journal-title":"N Engl J Med"},{"key":"10388_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","volume":"69","author":"D Tripathi","year":"2020","unstructured":"Tripathi D, Adrian JS, Peter CH, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut. 2020;69:1173\u20131192","journal-title":"Gut"},{"key":"10388_CR12","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","volume":"2","author":"JC Garc\u00eda-Pag\u00e1n","year":"2020","unstructured":"Garc\u00eda-Pag\u00e1n JC, Saffo S, Mandorfer M, et al. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep. 2020;2:100122","journal-title":"JHEP Rep"},{"issue":"4","key":"10388_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4251\/wjgo.v11.i4.310","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yi-Fan Wu, Yue Z-D, et al. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol. 2019;11(4):310\u2013321","journal-title":"World J Gastrointest Oncol"},{"key":"10388_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00270-017-1655-8","volume":"40","author":"B Qiu","year":"2017","unstructured":"Qiu B, Kai Li, Dong X, et al. Transjugular intrahepatic portosystemic shunt for portal hypertension in hepatocellular carcinoma with portal vein tumor thrombus. Cardiovasc Interv Radiol. 2017;40:1372\u20131382","journal-title":"Cardiovasc Interv Radiol"},{"key":"10388_CR15","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.3748\/wjg.v21.i43.12439","volume":"21","author":"B Qiu","year":"2015","unstructured":"Qiu B, Zhao M-F, Yue Z-D, et al. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol. 2015;21:12439\u201312447","journal-title":"World J Gastroenterol"},{"key":"10388_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.hepres.2003.08.002","volume":"28","author":"I Ikai","year":"2004","unstructured":"Ikai I. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res. 2004;28:21\u201329","journal-title":"Hepatol Res"},{"key":"10388_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","volume":"149","author":"T Auerbruch","year":"2015","unstructured":"Auerbruch T, Mengel M, Dollinger M, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149:660\u2013668","journal-title":"Gastroenterology"},{"key":"10388_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.surg.2014.12.003","volume":"157","author":"JO Marshall","year":"2015","unstructured":"Marshall JO, Robert JH, Henry OW, et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Surgery. 2015;157:1028\u20131045","journal-title":"Surgery"},{"key":"10388_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u2013752","journal-title":"J Hepatol"},{"key":"10388_CR20","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.24644","volume":"54","author":"M Iavarone","year":"2011","unstructured":"Iavarone M, Cabibbo G, Piscaglia F, et al. Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology. 2011;54:2055\u20132063","journal-title":"Hepatology"},{"key":"10388_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u2013213","journal-title":"Ann Surg"},{"key":"10388_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","volume":"54","author":"G Han","year":"2011","unstructured":"Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78\u201388","journal-title":"J Hepatol"},{"key":"10388_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ETTL, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + \u03b2-blocker for prevention of variceal rebleeding. Hepatology. 2016;63:581\u2013589","journal-title":"Hepatology"},{"key":"10388_CR24","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370\u20132379","journal-title":"N Engl J Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10388-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10388-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10388-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T20:40:31Z","timestamp":1669495231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10388-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10388"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10388-7","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yan Chen, Xuemei Ma, Xuefeng Zhang, Jing Luo, Linjing An, Yu Zhang, Xiujuan Chang, Zheng Dong, Wei Zhang, Huifang Kong, Jun Zhao, Huiguo Ding, Fuquan Liu and  Yongping Yang declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was reviewed and approved by the institution review board of Fifth Medical Center of Chinese PLA General Hospital, approval number [KY-2018-07-13-1]. The study was performed in accordance with the ethics standards of the institutional research committee and the recent Declaration of Helsinki, which conformed to the guidelines of the International Conference on Harmonization for Good Clinical Practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approvals statement"}},{"value":"The study protocol was approved by the ethics committees of all participating hospitals and followed the Guidelines for Good Clinical Practice in clinical trials. This study was conducted in accordance with the 1975 Declaration of Helsinki, and written informed consent was obtained from all patients after being fully informed of each procedure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}